Difficulty: Medium
Average Score: 67%
Practice
When treating a patient with asthma who is experiencing acute wheezing, which medication should be given to relieve the symptom?
Correct answer
A
Rationale
In the treatment of asthma with acute wheezing, the correct medication to relieve symptoms is a short-acting bronchodilator, which is option A. Short-acting bronchodilators, such as albuterol, act quickly to open up the airways by relaxing the smooth muscles in the lungs. This rapid bronchodilation helps to alleviate the wheezing and improve breathing in the acute setting.
Option B, a long-acting bronchodilator, is not appropriate for acute symptom relief as it has a slower onset of action and is more suitable for long-term management of asthma symptoms.
Option C, inhaled corticosteroids, are used as maintenance therapy to reduce airway inflammation and prevent asthma exacerbations but are not for immediate relief of acute wheezing.
Option D, a combination of methylxanthine and long-acting bronchodilator, is not the first-line treatment for acute wheezing in asthma. Methylxanthines like theophylline are not commonly used due to their narrow therapeutic index and potential for side effects.
In an educational context, understanding the appropriate use of asthma medications is crucial for healthcare professionals to provide effective and safe care to patients with asthma. Knowing when to use short-acting bronchodilators for acute symptom relief versus long-acting bronchodilators or corticosteroids for maintenance therapy is essential in managing asthma effectively. It is also important to consider individual patient factors and tailor treatment plans accordingly to optimize outcomes and improve patient quality of life.
Option B, a long-acting bronchodilator, is not appropriate for acute symptom relief as it has a slower onset of action and is more suitable for long-term management of asthma symptoms.
Option C, inhaled corticosteroids, are used as maintenance therapy to reduce airway inflammation and prevent asthma exacerbations but are not for immediate relief of acute wheezing.
Option D, a combination of methylxanthine and long-acting bronchodilator, is not the first-line treatment for acute wheezing in asthma. Methylxanthines like theophylline are not commonly used due to their narrow therapeutic index and potential for side effects.
In an educational context, understanding the appropriate use of asthma medications is crucial for healthcare professionals to provide effective and safe care to patients with asthma. Knowing when to use short-acting bronchodilators for acute symptom relief versus long-acting bronchodilators or corticosteroids for maintenance therapy is essential in managing asthma effectively. It is also important to consider individual patient factors and tailor treatment plans accordingly to optimize outcomes and improve patient quality of life.